At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06185 CANSINOBIO
Closed 03-16 16:08:22
33.980
+0.520
+1.55%
High34.000
Low33.260
Vol292.28K
Open33.980
D1 Closing33.460
Amplitude2.21%
Mkt Cap8.39B
Tradable Cap4.51B
Total Shares247.04M
T/O9.83M
T/O Rate0.22%
Tradable Shares132.67M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CanSino Biologics Surges Over 5% Following Malaysian PIC/S GMP Certification for Production Facility
Hong Kong Stocks Movement | Select Pharmaceutical Stocks Rally in Afternoon Session: CANSINOBIO (06185) Surges Over 10%, JUNSHI BIO (01877) Gains Over 5%
Hong Kong Stock Movement | CANSINOBIO (06185) Rises Nearly 6% Again; 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine Approved for Clinical Trials
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.